Yes, Gefitinib is used as targeted chemotherapy for advanced non-small-cell lung cancer (NSCLC) in patients with EGFR mutations. It offers better efficacy than traditional treatments.
Uses:
Gefitinib 250mg is used to treat certain types of lung cancer by blocking the activity of a protein (tyrosine kinase) that promotes cancer cell growth.
Side Effects:
Common side effects include rash, diarrhea, nausea, vomiting, dry skin, and loss of appetite. Some patients may experience serious effects like abdominal pain, black stools, or yellowing of the skin/eyes.
